Labat Africa drops profit guidance as virus impacts linger
The investment holding company’s revenue for the six months to end-February 2020 has plummeted
Investment holding company Labat Africa has withdrawn its five-year profit forecasts, including the projections it had for its current financial year to end-August 2020, due to the coronavirus pandemic.
The company is undergoing a turnaround as it seeks to get more exposure in the fast-growing cannabis industry.
It recently won a licence in Lesotho that allows it to trade in cannabis. Other recent deals that promise to expand Labat’s presence in the industry include the acquisition of CannAfrica, a cannabis education company, and the acquisition of Biodata, a medical research firm.
Labat joins a list of companies, including lender Nedbank and investment manager Quilter, that have withdrawn their guidance amid the fallout from the pandemic.
Labat’s revenue for the six months to end-February 2020 tumbled 35% to R219m, the company said on Friday in a trading statement.
Total income increased 180% to R2.8m from a previous loss of R3.5m while earnings surged 182% to 0.70c per share. Headline loss per share was up 73.7% for the period.
The company’s health-care and technology operations have performed reasonably well since March when the coronavirus surfaced in the country, but the lockdown has had a negative effect on its fuel volumes, Labat said.
Labat said it would be issuing a new forecast for its 2021 and 2022 financial years due to its venture into the hemp and cannabis industries.
Would you like to comment on this article or view other readers' comments?
Register (it’s quick and free) or sign in now.
Please read our Comment Policy before commenting.